BlackRock Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4.1M Buy
248,350
+2,672
+1% +$45.4K ﹤0.01% 1298
2016
Q3
$4.5M Sell
245,678
-3,700
-1% -$64.9K ﹤0.01% 1157
2016
Q2
$4M Hold
249,378
﹤0.01% 1184
2016
Q1
$2.39M Buy
249,378
+2,678
+1% +$38K ﹤0.01% 1427
2015
Q4
$4.43M Sell
246,700
-119,127
-33% -$2.2M ﹤0.01% 1133
2015
Q3
$8.15M Buy
+365,827
New +$9.88M ﹤0.01% 973

Other funds holding TDOC

BlackRock Group's TDOC Position: Q4 2016 in Review

BlackRock Group increased its Teladoc Health (TDOC) stake by 1.1% in Q4 2016, buying an estimated $45.4K and bringing the position to 248,350 shares worth $4.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

BlackRock Group first reported a position in TDOC in Q3 2015 and has held it in 6 quarters since. The position peaked at $8.15M in Q3 2015. 108 funds tracked by Wall St. Rank hold TDOC as of Q4 2016.

  • BlackRock Group held 248,350 shares of Teladoc Health worth $4.1M as of Q4 2016.
  • BlackRock Group bought 2,672 Teladoc Health shares in Q4 2016, an estimated $45.4K.
  • Teladoc Health made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1298 holding.
  • BlackRock Group first reported a position in Teladoc Health in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Group's Teladoc Health position peaked at $8.15M in Q3 2015.
  • 108 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.